Korea Innovative Medicines Consortium (KIMCo)

Overview

The Korea Innovative Medicines Consortium (KIMCo) is a non-profit foundation established to promote innovative growth in the pharmaceutical and biotechnology industries through open innovation. It serves as a collaboration platform for pharmaceutical and biotechnology companies, aiming to consolidate industry capabilities and actively promote co-investment and co-development initiatives. KIMCo also fosters private-public collaborations to enhance responses to infectious diseases and supports translational research for innovative medicines by encouraging cooperation among companies, universities, laboratories, hospitals, and governments. KIMCo's strategic focus includes accelerating the creation of innovative medicines, advancing pharmaceutical quality through manufacturing innovation, and strengthening communication and innovation within the industry. Its projects encompass co-investment and co-development in innovative medicines, development of technology-based medicines for global commercialization, and support for the advancement of manufacturing systems through government collaborations. Additionally, KIMCo organizes events like KIMCo Talk, Insight & Networking to promote industry communication. Through these initiatives, KIMCo aims to lead Korea to become a global pharmaceutical powerhouse by securing human rights in public health and advancing drug quality and manufacturing innovation. It strives to create a platform for collaboration that pools industry resources and capabilities to undertake projects that individual companies find difficult to pursue independently.

Investment Focus

• Focus on innovative medicines and healthcare ventures
• Collaboration with pharmaceutical and biotechnology companies
• Support for translational research and development

Portfolio Companies